English

Lameditech of South Korea was listed on the KOSDAQ exchange on the 17th

259
2024-06-26 11:15:40
See translation

On June 11, 2024, Korean laser medical equipment manufacturer Lameditech successfully completed its initial public offering and was listed on the KOSDAQ exchange on the 17th.

Last month, its public offering price was fixed at 16000 Korean won. In this public offering, Lameditech issued a total of 1298000 shares, raising approximately 20.8 billion Korean won. Since Lameditech's debut on KOSDAQ, as of 1pm on the 17th, its stock price has risen 98.1% to 31700 Korean won, with a market value of over 270 billion Korean won.

After investigation, Lameditech was founded in 2012 and is an enterprise that develops beauty and medical device products based on ultra small and high-power laser source technology. Lameditech's laser technology reduces the laser oscillator that determines the size of the laser by 90-95%, achieving high-power laser beam transmission while improving portability.

The company's main products include beauty equipment Puracell, excimer light K-Bum, and needle free laser blood collection equipment Handyray.
Among them, needle free laser blood collection equipment was the foundation of Lameditech's establishment. As early as 2018, the device obtained FDA certification in the United States. Up to now, Lameditech's first laser blood collection device has been launched in the United States, Japan, Europe and other overseas markets, which is crucial for the diagnosis and treatment of diabetes patients.

But in 2023, Lameditech's annual sales were only 2.9 billion Korean won, with an operating deficit of up to 3.5 billion Korean won. According to the securities documents corrected by Lameditech on the 28th, its sales in the first quarter of 2024 were approximately KRW 1 billion, and the confirmed sales in the second quarter as of now are approximately KRW 1.6 billion.

Regarding this, Lameditech expects its sales to reach 9.2 billion Korean won and operating profit to reach 1 billion Korean won in 2024. At the same time, as Lameditech is currently focusing on developing overseas markets, it has sufficient confidence in its performance growth after going public.
It is understood that Choi Jong seok is the current CEO of Lameditech and the largest shareholder and founder of the company. Choi holds a 5.26% stake in Lameditech.

In fact, Choi worked at B&B Systems, which was spun off from the SEMES and medical equipment departments of Samsung Electronics, and founded Lameditech after leaving.

It is worth mentioning that the third largest shareholder of Lameditech is Boditech, a company founded in 1998 that focuses on the production and sales of in vitro diagnostic equipment. In 2023, it achieved sales of KRW 134.2 billion and operating profit of KRW 28.5 billion.

As early as 2015, when Lamediatech was still in its infancy, Boditech invested 900 million Korean won and held 600000 shares. It did not make further investments for the next nine years and now holds 6.9% of Lamediatech's shares. There is a strong cooperative relationship between the two that goes beyond simple equity investment.

In May of this year, Boditech announced the signing of a global sales agreement with Lametech for the laser blood collection device Handyray, which will have a synergistic effect with Boditech's main in vitro analysis and diagnostic equipment.

Source: OFweek

Related Recommendations
  • A research team from the University of Chicago in the United States has demonstrated a new method for obtaining mid infrared emission using colloidal quantum dots (QDs)

    According to reports, a research team at the University of Chicago in the United States recently demonstrated a new method for obtaining mid infrared emission using colloidal quantum dots (QDs), which may open up new applications for mid infrared light sources.Colloidal quantum dots are a type of semiconductor nanocrystal material that provides a promising approach for the synthesis of light sourc...

    2023-09-21
    See translation
  • 3D printing giant Materialise reorganizes

    Recently, the stock price of Materialise, a well-known company in the 3D printing industry, plummeted by 35% overnight. This news was like a heavy bomb, instantly causing a storm in the industry! What exactly happened to Materialise, which was originally developing steadily? Why has there been such a significant drop in stock prices? Today, let's delve into the reasons behind this.The truth behind...

    03-03
    See translation
  • Researchers use desktop laser systems to generate ultrafast electrons

    In a mass particle accelerator, subatomic particles are accelerated to ultrahigh speeds that are comparable to the speed of light towards the target surface. The accelerated collision of subatomic particles produces unique interactions, enabling scientists to gain a deeper understanding of the fundamental properties of matter.Traditionally, laser based particle accelerators require expensive laser...

    2024-03-14
    See translation
  • Optimizing the phase focusing of laser accelerators

    With the help of on-chip accelerator technology, researchers at Stanford University are getting closer to manufacturing a miniature electron accelerator that can have various applications in industrial, medical, and physical research.Scientists have proven that silicon dielectric laser accelerators can now be used to accelerate and limit electrons, thereby producing concentrated high-energy electr...

    2024-02-29
    See translation
  • Historic Moment! The 100th TruLaser Cell Series 3D Five-Axis Laser Cutting Machine Successfully Rolls Off the Production Line in China

    Driven by the global trend of lightweighting in new energy vehicles (NEVs), TRUMPF has reached a significant milestone in Taicang, Jiangsu—the successful rollout of the 100th TruLaser Cell series 3D five-axis laser cutting machine. This achievement is more than just a numerical breakthrough; it symbolizes the deep integration of German technology with Chinese manufacturing and underscores TRUMPF's...

    03-14
    See translation